Clinical Trials Directory

Trials / Completed

CompletedNCT04476238

Inosine Energy Expenditure Study

Randomized Cross-over Trial to Investigate the Effect of Inosine on Human Energy Expenditure

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
8 (actual)
Sponsor
University Hospital, Basel, Switzerland · Academic / Other
Sex
Male
Age
18 Years – 40 Years
Healthy volunteers
Accepted

Summary

Investigators want to test whether the intake of the nucleoside inosine increases the human energy expenditure. Inosine occurs as a metabolic intermediate in the human body and is sometimes taken as a dietary supplement by athletes. For this purpose, investigators will measure the basal metabolic rate by indirect calorimetry. Study participants will then take inosine dissolved in water or placebo and energy expenditure will be assessed again.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTInosine2 grams of inosine dissolved in 250 ml water taken by mouth
OTHERPlacebo250 ml water taken by mouth

Timeline

Start date
2022-02-28
Primary completion
2022-12-31
Completion
2023-04-30
First posted
2020-07-20
Last updated
2023-09-28

Locations

1 site across 1 country: Switzerland

Source: ClinicalTrials.gov record NCT04476238. Inclusion in this directory is not an endorsement.

Inosine Energy Expenditure Study (NCT04476238) · Clinical Trials Directory